✦ LIBER ✦

A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer

✍ Scribed by Tu, Yifan (author);Hershman, Dawn L. (author);Bhalla, Kapil (author);Fiskus, Warren (author);Pellegrino, Christine M. (author);Andreopoulou, Eleni (author);Makower, Della (author);Kalinsky, Kevin (author);Fehn, Karen (author);Fineberg, Susan (author);Negassa, Abdissa (author);Montgomery, Leslie L. (author);Wiechmann, Lisa S. (author);Alpaugh, R. Katherine (author);Huang, Min (author);Sparano, Joseph A. (author)

Book ID: 125356852
Publisher: Springer New York LLC
Year: 2014
Tongue: English
Weight: 447 KB
Volume: 146
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-014-3008-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I-II study of the histone deacet

A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer

✍ Tu, Yifan (author);Hershman, Dawn L. (author);Bhalla, Kapil (author);Fiskus, War 📂 Article 📅 2014 🏛 Springer New York LLC 🌐 English ⚖ 447 KB

Phase I–II study of the farnesyl transfe

Phase I–II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin–cyclophosphamide in HER2/neu-negative inflammatory carcinoma and non-inflammatory estrogen receptor-positive breast carcinoma

✍ Andreopoulou, Eleni; Vigoda, Ivette S.; Valero, Vicente; Hershman, Dawn L.; Rapt 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 216 KB

Phase I–II study of vorinostat plus pacl

Phase I–II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo

✍ B. Ramaswamy; W. Fiskus; B. Cohen; C. Pellegrino; D. L. Hershman; E. Chuang; The 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 592 KB

A phase II study of sequential 5-fluorou

A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01)

✍ Riccardi, A. 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 69 KB

Results of a phase II study of liposomal

Results of a phase II study of liposomal doxorubicin (Myocet®) in combination with weekly paclitaxel and trastuzumab (Herceptin®) In patients with HER2-positive locally advanced or metastatic breast cancer (LA/MBC)

✍ J Baselga; M.A Climent; A Lluch; J Hornedo; P Gascon; A.T Sanchez; V Guillem; H 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Efficacy and toxicity of vinorelbine wit

Efficacy and toxicity of vinorelbine with doxorubicin/cyclophosphamide combination chemotherapy in a phase I-II study for advanced or recurrent breast cancer patients

✍ Toshiaki Saeki; Shigemitsu Takashima; Masami Ogita; Toshio Tabei; Isamu Adachi; 📂 Article 📅 2006 🏛 Springer Japan 🌐 English ⚖ 549 KB